Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice

J Allergy Clin Immunol. 2015 Jul;136(1):159-68. doi: 10.1016/j.jaci.2015.04.020.

Abstract

Background: Recently, we developed a humanized mouse model of allergen-induced IgE-dependent gut inflammation in PBMC-engrafted immunodeficient mice.

Objective: In the present study, we wanted to investigate the role of regulatory T (Treg) cells and their activation status in this model.

Methods: Nonobese diabetic-severe combined immunodeficiency-γc(-/-) mice were injected intraperitoneally with human PBMCs from allergic donors together with the respective allergen or NaCl as control in the presence or absence of different concentrations of CD4(+)CD25(+) Treg cells of the same donor. After an additional allergen boost 1 week later, mice were challenged with the allergen rectally on day 21 and gut inflammation was monitored by a high-resolution video mini-endoscopic system evaluating translucency, granularity, fibrin production, vascularity, and stool.

Results: Allergen-specific human IgE in mouse sera, which was detectable only in PBMC plus allergen-treated mice, was strongly inhibited by coinjection of Treg cells at a ratio of at least 1:10. Consequently, the presence of Treg cells significantly decreased IgE-dependent allergen-induced gut inflammation after rectal allergen challenge. In addition, Treg cells reduced allergen-specific proliferation and cytokine production of recovered human CD4(+) T cells in vitro. Activation of Treg cells before injection further increased all inhibitory effects. Prevention of gut inflammation also occurred by the administration of glycoprotein A repetitions predominant, a molecule expressed by activated Treg cells, whereas its blockade completely abrogated inhibition by Treg cells.

Conclusions: These results demonstrate that allergen-specific gut inflammation in human PBMC-engrafted mice can be avoided by enhancing the numbers or activity of autologous Treg cells, which is of great interest for therapeutic intervention of allergic diseases of the intestine.

Keywords: Humanized mice; IgE; allergen; colon; inflammation; regulatory T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / administration & dosage
  • Animals
  • Antibodies, Blocking / pharmacology
  • Antibody Formation / drug effects
  • CD4 Antigens / metabolism
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Disease Models, Animal
  • Female
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Hypersensitivity / immunology*
  • Immunoglobulin E / blood
  • Immunosuppression Therapy
  • Inflammation / immunology*
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Intestines / immunology*
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / transplantation
  • Male
  • Membrane Proteins / immunology
  • Mice
  • Mice, SCID
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / transplantation

Substances

  • Allergens
  • Antibodies, Blocking
  • CD4 Antigens
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Interleukin-2 Receptor alpha Subunit
  • LRRC32 protein, human
  • Membrane Proteins
  • Immunoglobulin E